Jefferies Financial Group

Selected news for the capital firm - Jefferies Financial Group, collected since 4/2019. This capital firm shares healthcare news with Medical Research, GlaxoSmithKline, Fresenius Medical Care, COVID-19, Wolfe Research and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Buy” by Analysts dispatchtribunal.com ... recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $40.67.Several analysts recently weighed in on PRVA shares. Jefferies Financial Group started coverage on Privia Health Group in a research note on Monday, January 3rd. They issued a “buy” rating and a $33.00 price objective on the stock. SVB Leerink lifted their price ...
1/12/2022 GoodRx (NASDAQ:GDRX) Stock Rating Upgraded by Zacks Investment Research dispatchtribunal.com ... weighed in on GDRX. The Goldman Sachs Group initiated coverage on shares of GoodRx in a research report on Friday. They set a “buy” rating and a $43.00 target price on the stock. Jefferies Financial Group initiated coverage on shares of GoodRx in a research report on Wednesday, December 1st. They issued a “buy” rating and a $47.00 price target on the stock. SVB Leerink reduced their price ...
1/12/2022 GoodRx (NASDAQ:GDRX) Stock Rating Upgraded by Zacks Investment Research thelincolnianonline.com ... to Zacks, “GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. “A number of other equities research analysts have also issued reports on GDRX. Jefferies Financial Group started coverage on GoodRx in a research note on Wednesday, December 1st. They issued a “buy” rating and a $47.00 target price on the stock. Robert W. Baird reduced their target price ...
1/12/2022 AstraZeneca PLC (NASDAQ:AZN) Sees Significant Drop in Short Interest - The Cerbat Gem thecerbatgem.com ... to-cover ratio is presently 1.3 days.AZN has been the subject of several research reports. SVB Leerink reissued a “buy” rating on shares of AstraZeneca in a report on Sunday, December 12th. Jefferies Financial Group cut AstraZeneca from a “buy” rating to a “hold” rating and set a $54.00 price target for the company. in a report on Tuesday, December 7th. TheStreet cut AstraZeneca from a ...
1/12/2022 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) to Post FY2026 Earnings of $3.15 Per Share, Jefferies Financial Group Forecasts - Transcript Daily transcriptdaily.com Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP) – Analysts at Jefferies Financial Group issued their FY2026 earnings per share (EPS) estimates for shares of Aurinia Pharmaceuticals in a research report issued on Sunday, January 9th. Jefferies Financial Group analyst M. Raycroft anticipates that the biotechnology company will post earnings per share of $3.15 for the year. Jefferies Financial Group currently has a “Buy” rating on the stock.Get Aurinia ...
1/12/2022 Oak Street Health (NYSE:OSH) Rating Lowered to Market Perform at Cowen dispatchtribunal.com ... Wednesday, October 13th. Morgan Stanley reaffirmed an “equal weight” rating and set a $33.00 target price (down from $44.00) on shares of Oak Street Health in a research note on Friday, December 17th. Jefferies Financial Group began coverage on shares of Oak Street Health in a research note on Wednesday, October 20th. They set a “buy” rating and a $50.00 target price on the stock. Finally, Zacks Investment ...
1/12/2022 Brokers Set Expectations for Aurinia Pharmaceuticals Inc.'s FY2026 Earnings (NASDAQ:AUPH) theenterpriseleader.com Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP) – Equities researchers at Jefferies Financial Group issued their FY2026 earnings per share (EPS) estimates for shares of Aurinia Pharmaceuticals in a report issued on Sunday, January 9th. Jefferies Financial Group analyst M. Raycroft expects that the biotechnology company will post earnings per share of $3.15 for the year. Jefferies Financial Group has a “Buy” rating on the stock.Several other equities ...
1/12/2022 FY2021 Earnings Forecast for Medical Properties Trust, Inc. (NYSE:MPW) Issued By Jefferies Financial Group - Slater Sentinel slatersentinel.com Medical Properties Trust, Inc. (NYSE:MPW) – Investment analysts at Jefferies Financial Group cut their FY2021 EPS estimates for Medical Properties Trust in a report issued on Monday, January 10th. Jefferies Financial Group analyst J. Petersen now forecasts that the real estate investment trust will post earnings per share of $1.75 for the year, down from their prior estimate of $1.76. Jefferies Financial Group also issued estimates for Medical Properties ...
1/12/2022 Medical Properties Trust, Inc. Expected to Post FY2021 Earnings of $1.75 Per Share (NYSE:MPW) rivertonroll.com Medical Properties Trust, Inc. (NYSE:MPW) – Analysts at Jefferies Financial Group lowered their FY2021 earnings per share (EPS) estimates for shares of Medical Properties Trust in a research report issued to clients and investors on Monday, January 10th. Jefferies Financial Group analyst J. Petersen now anticipates that the real estate investment trust will post earnings of $1.75 per share for the year, down from their prior forecast of $1.76 ...
1/12/2022 BioNTech (NASDAQ:BNTX) Raised to “Strong-Buy” at Zacks Investment Research com-unik.info ... set a market perform rating for the company in a research note on Tuesday, October 5th. Bryan, Garnier & Co set a $359.00 target price on BioNTech in a research note on Tuesday, October 5th. Jefferies Financial Group set a $230.00 target price on BioNTech in a research note on Wednesday, December 8th. The Goldman Sachs Group set a $433.00 target price on BioNTech in a research note on Wednesday, September ...
1/11/2022 Jefferies Financial Group Comments on LivaNova PLC's FY2021 Earnings (NASDAQ:LIVN) etfdailynews.com LivaNova PLC (NASDAQ:LIVN) – Jefferies Financial Group issued their FY2021 EPS estimates for shares of LivaNova in a report released on Thursday, January 6th. Jefferies Financial Group analyst Z. Weiner anticipates that the company will post earnings per share of $1.54 for the year. Jefferies Financial Group also issued estimates for LivaNova’s Q4 2021 earnings at $0.51 EPS, Q1 2022 earnings at $0.54 EPS, Q2 2022 earnings at ...
1/11/2022 Stryker Co. (NYSE:SYK) to Post FY2021 Earnings of $9.11 Per Share, Jefferies Financial Group Forecasts Dakota Financial News Stryker Co. (NYSE:SYK) – Stock analysts at Jefferies Financial Group issued their FY2021 earnings estimates for shares of Stryker in a report issued on Thursday, January 6th. Jefferies Financial Group analyst F. Pinal anticipates that the medical technology company will post earnings per share of $9.11 for the year. Jefferies Financial Group also issued estimates for Stryker’s Q4 2021 earnings at $2.73 EPS, Q1 2022 earnings at $2.42 ...
1/11/2022 Zacks Investment Research Lowers Health Catalyst (NASDAQ:HCAT) to Hold etfdailynews.com ... note on Sunday, September 26th. BTIG Research began coverage on Health Catalyst in a research note on Thursday, October 14th. They issued a “buy” rating and a $60.00 price objective on the stock. Jefferies Financial Group began coverage on Health Catalyst in a research note on Wednesday, December 1st. They issued a “hold” rating and a $48.00 price objective on the stock. Finally, Citigroup cut their price objective ...
1/11/2022 Zacks Investment Research Lowers Health Catalyst (NASDAQ:HCAT) to Hold - Mayfield Recorder Mayfield Recorder ... of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. “Get Health Catalyst alerts: Other analysts also recently issued reports about the stock. Jefferies Financial Group initiated coverage on shares of Health Catalyst in a research report on Wednesday, December 1st. They issued a “hold” rating and a $48.00 price objective on the stock. SVB Leerink reiterated a ...
1/11/2022 Q4 2022 Earnings Forecast for Exelixis, Inc. Issued By Piper Sandler (NASDAQ:EXEL) zolmax.com ... 2nd. Royal Bank of Canada decreased their target price on shares of Exelixis from $32.00 to $31.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 3rd. Jefferies Financial Group began coverage on shares of Exelixis in a research report on Wednesday, October 6th. They set a “buy” rating and a $28.00 target price on the stock. Finally, Zacks Investment Research lowered ...
1/11/2022 Short Interest in AstraZeneca PLC (NASDAQ:AZN) Declines By 16.8% - Mayfield Recorder Mayfield Recorder ... November 30th total of 7,550,000 shares. Based on an average daily trading volume, of 4,950,000 shares, the days-to-cover ratio is presently 1.3 days.Several research analysts have weighed in on AZN shares. Jefferies Financial Group downgraded AstraZeneca from a “buy” rating to a “hold” rating and set a $54.00 target price on the stock. in a research note on Tuesday, December 7th. UBS Group restated a ...
1/11/2022 Research Analysts Offer Predictions for Lantheus Holdings, Inc.'s FY2021 Earnings (NASDAQ:LNTH) - Stock Observer thestockobserver.com Lantheus Holdings, Inc. (NASDAQ:LNTH) – Investment analysts at Jefferies Financial Group issued their FY2021 earnings estimates for shares of Lantheus in a report issued on Thursday, January 6th. Jefferies Financial Group analyst Z. Weiner forecasts that the medical equipment provider will earn $0.27 per share for the year. Jefferies Financial Group also issued estimates for Lantheus’ Q4 2021 earnings at $0.16 EPS, Q1 2022 earnings at $0.17 EPS ...
1/11/2022 Jefferies Financial Group Weighs in on DexCom, Inc.'s FY2021 Earnings (NASDAQ:DXCM) - Ticker Report Ticker Report DexCom, Inc. (NASDAQ:DXCM) – Investment analysts at Jefferies Financial Group issued their FY2021 earnings estimates for shares of DexCom in a research report issued to clients and investors on Thursday, January 6th. Jefferies Financial Group analyst F. Pinal expects that the medical device company will post earnings of $2.90 per share for the year. Jefferies Financial Group currently has a “Buy” rating and a $655.00 target price on ...
1/11/2022 Cytosorbents Co. Forecasted to Post FY2021 Earnings of ($0.44) Per Share (NASDAQ:CTSO) - Ticker Report Ticker Report Cytosorbents Co. (NASDAQ:CTSO) – Equities research analysts at Jefferies Financial Group issued their FY2021 earnings per share (EPS) estimates for shares of Cytosorbents in a report released on Thursday, January 6th. Jefferies Financial Group analyst F. Pinal expects that the medical research company will post earnings of ($0.44) per share for the year. Jefferies Financial Group also issued estimates for Cytosorbents’ Q4 2021 earnings at ($0.08) EPS, Q1 ...
1/11/2022 Lantheus Holdings, Inc. to Post FY2021 Earnings of $0.27 Per Share, Jefferies Financial Group Forecasts (NASDAQ:LNTH) The Markets Daily Lantheus Holdings, Inc. (NASDAQ:LNTH) – Stock analysts at Jefferies Financial Group issued their FY2021 earnings estimates for shares of Lantheus in a note issued to investors on Thursday, January 6th. Jefferies Financial Group analyst Z. Weiner anticipates that the medical equipment provider will post earnings of $0.27 per share for the year. Jefferies Financial Group also issued estimates for Lantheus’ Q4 2021 earnings at $0.16 EPS, Q1 2022 ...